Esther Cho, SVP, General Counsel at Keros Therapeutics, Inc. (KROS), sold 4,745 shares at $16.35 ($78K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Open-market sale of $78k KROS by SVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.